Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

Clinical Research

New iPad App Tracks MS Patient Course

Researchers at the University of California, San Francisco, have developed a new tool that allows clinicians to track an individual’s disease course over time and compare it to a core data set of other MS patients. The tool is currently in beta-testing at UCSF.
Pierre-Antoine Gourraud, Ph.D., of the University of California, San Francisco, and I huddled around his iPad and...
Clinical Research, People

MS Family Planning 201: Breastfeeding, DMTs, and the Risk of Postpartum Relapse

Modersohn-Becker, Stillende Mutter
The risk of relapse is higher in the postpartum period, but there are conflicting suggestions for women with MS about reducing this risk. Can exclusive breastfeeding alone prevent relapses? How soon after delivery should DMTs be reintroduced? Are any DMTs safe to take while breastfeeding?
For any parent, the first few months after delivery are tumultuous—adapting to a new...
Clinical Research

MS Research Roundup: October 3, 2014

Research Roundup logo
Stem Cells Pass Safety Trials; Generic Similar to Copaxone; Epigenetic Differences in Monocytes and Macrophages; One Brain, Many Genomes
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development, Laboratory Research, Methods

Phase 2 Trial Suggests RPC1063 Is as Effective as—and Safer Than—Fingolimod

RPC1063, an experimental oral immunomodulator, is looking promising as it progresses through clinical testing. At the ACTRIMS-ECTRIMS meeting in September, Amit Bar-Or presented results of the phase 2 trial suggesting the drug is as effective as and safer than its counterpart, fingolimod.
RPC1063 may open the door to more convenient treatment options for relapsing-remitting MS, if...
Clinical Research, Drug Development


Subscribe to RSS - Clinical Research